Last 12 months
Inside the activity.
1 purchase rows · 42 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 3 |
| Dec 2025 | 0 | 12 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 11 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 5 |
| Jun 2026 | 0 | 3 |
| Jul 2026 | 0 | 2 |
| Aug 2026 | 1 | 6 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 14, 2024 Filed Mar 18, 2024 22:20 UTC |
Hassan FredDirector
|
GrantOption to Purchase Common Stock (Right to Buy) · Derivative | 101,626 | $0.00 Strike: $1.43 | $0.00 |
DisclosureSEC source: 0000950103-24-003955 · dp208508_4-hassan.xml · derivative · entry 3 Hassan Fred · CIK 0001110744 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,626 Underlying: Common Stock · 101,626 shares Expires 2034-03-14 Read SEC document |
| March 14, 2024 Filed Mar 18, 2024 22:20 UTC |
Hassan FredDirector
|
GrantRestricted Stock Units · Derivative | 87,412 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-24-003955 · dp208508_4-hassan.xml · derivative · entry 2 Hassan Fred · CIK 0001110744 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,412 Underlying: Common Stock · 87,412 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. F3 · derivative.exercise_date: The RSUs vest in full on March 14, 2025. F3 · derivative.expiration_date: The RSUs vest in full on March 14, 2025. Read SEC document |
| March 14, 2024 Filed Mar 18, 2024 22:20 UTC |
Hassan FredDirector
|
GrantCommon Stock | 44,055 | $1.43 | $62,998.65 |
DisclosureSEC source: 0000950103-24-003955 · dp208508_4-hassan.xml · nonDerivative · entry 1 Hassan Fred · CIK 0001110744 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,029,834 F1 · price: The shares were issued to the reporting person in lieu of an annual retainer of $62,999. Read SEC document |
| March 14, 2024 Filed Mar 18, 2024 22:16 UTC |
KINDLER JEFFREY BDirector
|
GrantOption to Purchase Common Stock (Right to Buy) · Derivative | 101,626 | $0.00 Strike: $1.43 | $0.00 |
DisclosureSEC source: 0000950103-24-003952 · dp208507_4-kindler.xml · derivative · entry 3 KINDLER JEFFREY B · CIK 0001174454 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,626 Underlying: Common Stock · 101,626 shares Expires 2034-03-14 Read SEC document |
| March 14, 2024 Filed Mar 18, 2024 22:16 UTC |
KINDLER JEFFREY BDirector
|
GrantRestricted Stock Units · Derivative | 87,412 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-24-003952 · dp208507_4-kindler.xml · derivative · entry 2 KINDLER JEFFREY B · CIK 0001174454 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,412 Underlying: Common Stock · 87,412 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. F3 · derivative.exercise_date: The RSUs vest in full on March 14, 2025. F3 · derivative.expiration_date: The RSUs vest in full on March 14, 2025. Read SEC document |
| March 14, 2024 Filed Mar 18, 2024 22:16 UTC |
KINDLER JEFFREY BDirector
|
GrantCommon Stock | 48,251 | $1.43 | $68,998.93 |
DisclosureSEC source: 0000950103-24-003952 · dp208507_4-kindler.xml · nonDerivative · entry 1 KINDLER JEFFREY B · CIK 0001174454 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 393,363 F1 · price: The shares were issued to the reporting person in lieu of an annual retainer of $68,999. Read SEC document |
| March 14, 2024 Filed Mar 18, 2024 18:19 UTC |
Gupta Vinita DDirector
|
GrantOption to Purchase Common Stock (Right to Buy) · Derivative | 101,626 | $0.00 Strike: $1.43 | $0.00 |
DisclosureSEC source: 0000950103-24-003954 · dp208509_4-gupta.xml · derivative · entry 3 Gupta Vinita D · CIK 0001705209 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,626 Underlying: Common Stock · 101,626 shares Expires 2034-03-14 Read SEC document |
| March 14, 2024 Filed Mar 18, 2024 18:19 UTC |
Gupta Vinita DDirector
|
GrantRestricted Stock Units · Derivative | 87,412 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-24-003954 · dp208509_4-gupta.xml · derivative · entry 2 Gupta Vinita D · CIK 0001705209 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,412 Underlying: Common Stock · 87,412 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. F3 · derivative.exercise_date: The RSUs vest in full on March 14, 2025. F3 · derivative.expiration_date: The RSUs vest in full on March 14, 2025. Read SEC document |
| March 14, 2024 Filed Mar 18, 2024 18:19 UTC |
Gupta Vinita DDirector
|
GrantCommon Stock | 44,055 | $1.43 | $62,998.65 |
DisclosureSEC source: 0000950103-24-003954 · dp208509_4-gupta.xml · nonDerivative · entry 1 Gupta Vinita D · CIK 0001705209 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 452,622 F1 · price: The shares were issued to the reporting person in lieu of an annual retainer of $62,999. Read SEC document |
| March 14, 2024 Filed Mar 18, 2024 22:18 UTC |
ALVAREZ CESAR LDirector
|
GrantOption to Purchase Common Stock (Right to Buy) · Derivative | 101,626 | $0.00 Strike: $1.43 | $0.00 |
DisclosureSEC source: 0000950103-24-003953 · dp208506_4-alvarez.xml · derivative · entry 3 ALVAREZ CESAR L · CIK 0001220297 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,626 Underlying: Common Stock · 101,626 shares Expires 2034-03-14 Read SEC document |
| March 14, 2024 Filed Mar 18, 2024 22:18 UTC |
ALVAREZ CESAR LDirector
|
GrantRestricted Stock Units · Derivative | 87,412 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-24-003953 · dp208506_4-alvarez.xml · derivative · entry 2 ALVAREZ CESAR L · CIK 0001220297 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,412 Underlying: Common Stock · 87,412 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. F3 · derivative.exercise_date: The RSUs vest in full on March 14, 2025. F3 · derivative.expiration_date: The RSUs vest in full on March 14, 2025. Read SEC document |
| March 14, 2024 Filed Mar 18, 2024 22:18 UTC |
ALVAREZ CESAR LDirector
|
GrantCommon Stock | 43,706 | $1.43 | $62,499.58 |
DisclosureSEC source: 0000950103-24-003953 · dp208506_4-alvarez.xml · nonDerivative · entry 1 ALVAREZ CESAR L · CIK 0001220297 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 569,933 F1 · price: The shares were issued to the reporting person in lieu of an annual retainer of $62,500. Read SEC document |
| March 14, 2024 Filed Mar 18, 2024 22:14 UTC |
MITCHELL DEAN JDirector
|
GrantOption to Purchase Common Stock (Right to Buy) · Derivative | 101,626 | $0.00 Strike: $1.43 | $0.00 |
DisclosureSEC source: 0000950103-24-003951 · dp208510_4-mitchell.xml · derivative · entry 3 MITCHELL DEAN J · CIK 0001199297 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,626 Underlying: Common Stock · 101,626 shares Expires 2034-03-14 Read SEC document |
| March 14, 2024 Filed Mar 18, 2024 22:14 UTC |
MITCHELL DEAN JDirector
|
GrantRestricted Stock Units · Derivative | 87,412 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-24-003951 · dp208510_4-mitchell.xml · derivative · entry 2 MITCHELL DEAN J · CIK 0001199297 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,412 Underlying: Common Stock · 87,412 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. F3 · derivative.exercise_date: The RSUs vest in full on March 14, 2025. F3 · derivative.expiration_date: The RSUs vest in full on March 14, 2025. Read SEC document |
| March 14, 2024 Filed Mar 18, 2024 22:14 UTC |
MITCHELL DEAN JDirector
|
GrantCommon Stock | 39,510 | $1.43 | $56,499.30 |
DisclosureSEC source: 0000950103-24-003951 · dp208510_4-mitchell.xml · nonDerivative · entry 1 MITCHELL DEAN J · CIK 0001199297 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 503,183 F1 · price: The shares were issued to the reporting person in lieu of an annual retainer of $56,499. Read SEC document |
| March 14, 2024 Filed Mar 18, 2024 22:09 UTC |
Frank StevenDirector
|
GrantOption to Purchase Common Stock (Right to Buy) · Derivative | 101,626 | $0.00 Strike: $1.43 | $0.00 |
DisclosureSEC source: 0000950103-24-003949 · dp208512_4-frank.xml · derivative · entry 3 Frank Steven · CIK 0001583886 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,626 Underlying: Common Stock · 101,626 shares Expires 2034-03-14 Read SEC document |
| March 14, 2024 Filed Mar 18, 2024 22:09 UTC |
Frank StevenDirector
|
GrantRestricted Stock Units · Derivative | 87,412 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-24-003949 · dp208512_4-frank.xml · derivative · entry 2 Frank Steven · CIK 0001583886 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,412 Underlying: Common Stock · 87,412 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. F3 · derivative.exercise_date: The RSUs vest in full on March 14, 2025. F3 · derivative.expiration_date: The RSUs vest in full on March 14, 2025. Read SEC document |
| March 14, 2024 Filed Mar 18, 2024 22:09 UTC |
Frank StevenDirector
|
GrantCommon Stock | 34,965 | $1.43 | $49,999.95 |
DisclosureSEC source: 0000950103-24-003949 · dp208512_4-frank.xml · nonDerivative · entry 1 Frank Steven · CIK 0001583886 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,024,160 F1 · price: The shares were issued to the reporting person in lieu of an annual retainer of $50,000. Read SEC document |
| March 14, 2024 Filed Mar 18, 2024 22:12 UTC |
Turley James SDirector
|
GrantOption to Purchase Common Stock (Right to Buy) · Derivative | 101,626 | $0.00 Strike: $1.43 | $0.00 |
DisclosureSEC source: 0000950103-24-003950 · dp208511_4-turley.xml · derivative · entry 3 Turley James S · CIK 0001580994 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,626 Underlying: Common Stock · 101,626 shares Expires 2034-03-14 Read SEC document |
| March 14, 2024 Filed Mar 18, 2024 22:12 UTC |
Turley James SDirector
|
GrantRestricted Stock Units · Derivative | 87,412 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-24-003950 · dp208511_4-turley.xml · derivative · entry 2 Turley James S · CIK 0001580994 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,412 Underlying: Common Stock · 87,412 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. F3 · derivative.exercise_date: The RSUs vest in full on March 14, 2025. F3 · derivative.expiration_date: The RSUs vest in full on March 14, 2025. Read SEC document |
| March 14, 2024 Filed Mar 18, 2024 22:12 UTC |
Turley James SDirector
|
GrantCommon Stock | 43,706 | $1.43 | $62,499.58 |
DisclosureSEC source: 0000950103-24-003950 · dp208511_4-turley.xml · nonDerivative · entry 1 Turley James S · CIK 0001580994 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 472,441 F1 · price: The shares were issued to the reporting person in lieu of an annual retainer of $62,500. Read SEC document |
| March 09, 2024 Filed Mar 12, 2024 17:36 UTC |
KIRK RANDAL JDirector · 10% owner
|
Exercise / conversionRestricted Stock Units · Derivative | 213,675 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-24-021905 · marketforms-65153.xml · derivative · entry 31 KIRK RANDAL J · CIK 0001091823 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · by R.J. Kirk DOT Disclosed balance after: 0 Underlying: Common Stock · 213,675 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of issuer common stock. The restricted stock units were granted on March 9, 2023 and vested in their entirety on the one-year anniversary of the date of grant. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one (1) share of issuer common stock. The restricted stock units were granted on March 9, 2023 and vested in their entirety on the one-year anniversary of the date of grant. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one (1) share of issuer common stock. The restricted stock units were granted on March 9, 2023 and vested in their entirety on the one-year anniversary of the date of grant. Read SEC document |
| March 09, 2024 Filed Mar 12, 2024 17:36 UTC |
KIRK RANDAL JDirector · 10% owner
|
Exercise / conversionCommon Stock | 213,675 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-24-021905 · marketforms-65153.xml · nonDerivative · entry 1 KIRK RANDAL J · CIK 0001091823 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · by R.J. Kirk DOT Disclosed balance after: 32,051,461 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of issuer common stock. The restricted stock units were granted on March 9, 2023 and vested in their entirety on the one-year anniversary of the date of grant. F2 · ownership.nature: Randal J. Kirk controls each of R.J. Kirk Declaration of Trust ("R.J. Kirk DOT"), Parkview 2020 Limited Partnership ("Parkview 2020"), JPK 2008 LLC ("JPK 2008"), JPK 2009 LLC ("JPK 2009"), JPK 2012 LLC ("JPK 2012"), MGK 2008 LLC ("MGK 2008"), MGK 2009 LLC ("MGK 2009"), MGK 2011 LLC ("MGK 2011"), ZSK 2008 LLC ("ZSK 2008"), ZSK 2009 LLC ("ZSK 2009"), Kellie L. Banks (2009) Long Term Trust ("Kellie L. Banks LTT"), Third Security Senior Staff 2015 LLC ("Sr. Staff 2015"), Third Security Staff 2015 LLC ("Staff 2015"), Kapital Joe, LLC ("Kapital Joe"), Lotus Capital (2000) Company, Inc. ("Lotus"), and Sunset 2020 LLC ("Sunset 2020"). Shares held by these entities may be deemed to be beneficially owned (as defined under Rule 13d-3 promulgated under the Securities Exchange Act of 1934, as amended) by Mr. Kirk. Mr. Kirk disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein. Read SEC document |
| March 09, 2024 Filed Mar 12, 2024 23:53 UTC |
Hassan FredDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 106,837 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-24-003746 · dp208299_4-hassan.xml · derivative · entry 2 Hassan Fred · CIK 0001110744 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 106,837 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. F2 · derivative.exercise_date: The RSUs vested in full on March 9, 2024. F2 · derivative.expiration_date: The RSUs vested in full on March 9, 2024. Read SEC document |
| March 09, 2024 Filed Mar 12, 2024 23:53 UTC |
Hassan FredDirector
|
Exercise / conversionCommon Stock | 106,837 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950103-24-003746 · dp208299_4-hassan.xml · nonDerivative · entry 1 Hassan Fred · CIK 0001110744 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 985,779 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. Read SEC document |
| March 09, 2024 Filed Mar 12, 2024 23:50 UTC |
KINDLER JEFFREY BDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 106,837 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-24-003742 · dp208302_4-kindler.xml · derivative · entry 2 KINDLER JEFFREY B · CIK 0001174454 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 106,837 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. F2 · derivative.exercise_date: The RSUs vested in full on March 9, 2024. F2 · derivative.expiration_date: The RSUs vested in full on March 9, 2024. Read SEC document |
| March 09, 2024 Filed Mar 12, 2024 23:50 UTC |
KINDLER JEFFREY BDirector
|
Exercise / conversionCommon Stock | 106,837 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950103-24-003742 · dp208302_4-kindler.xml · nonDerivative · entry 1 KINDLER JEFFREY B · CIK 0001174454 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 345,112 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. Read SEC document |
| March 09, 2024 Filed Mar 12, 2024 19:53 UTC |
Gupta Vinita DDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 106,837 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-24-003745 · dp208303_4-gupta.xml · derivative · entry 2 Gupta Vinita D · CIK 0001705209 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 106,837 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. F2 · derivative.exercise_date: The RSUs vested in full on March 9, 2024. F2 · derivative.expiration_date: The RSUs vested in full on March 9, 2024. Read SEC document |
| March 09, 2024 Filed Mar 12, 2024 19:53 UTC |
Gupta Vinita DDirector
|
Exercise / conversionCommon Stock | 106,837 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950103-24-003745 · dp208303_4-gupta.xml · nonDerivative · entry 1 Gupta Vinita D · CIK 0001705209 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 408,567 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. Read SEC document |
| March 09, 2024 Filed Mar 12, 2024 23:55 UTC |
Frank StevenDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 106,837 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-24-003748 · dp208304_4-frank.xml · derivative · entry 2 Frank Steven · CIK 0001583886 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 106,837 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. F2 · derivative.exercise_date: The RSUs vested in full on March 9, 2024. F2 · derivative.expiration_date: The RSUs vested in full on March 9, 2024. Read SEC document |
| March 09, 2024 Filed Mar 12, 2024 23:55 UTC |
Frank StevenDirector
|
Exercise / conversionCommon Stock | 106,837 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950103-24-003748 · dp208304_4-frank.xml · nonDerivative · entry 1 Frank Steven · CIK 0001583886 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 989,195 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. Read SEC document |
| March 09, 2024 Filed Mar 12, 2024 23:54 UTC |
MITCHELL DEAN JDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 106,837 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-24-003747 · dp208301_4-mitchell.xml · derivative · entry 2 MITCHELL DEAN J · CIK 0001199297 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 106,837 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. F2 · derivative.exercise_date: The RSUs vested in full on March 9, 2024. F2 · derivative.expiration_date: The RSUs vested in full on March 9, 2024. Read SEC document |
| March 09, 2024 Filed Mar 12, 2024 23:54 UTC |
MITCHELL DEAN JDirector
|
Exercise / conversionCommon Stock | 106,837 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950103-24-003747 · dp208301_4-mitchell.xml · nonDerivative · entry 1 MITCHELL DEAN J · CIK 0001199297 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 463,673 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. Read SEC document |
| March 09, 2024 Filed Mar 12, 2024 23:52 UTC |
ALVAREZ CESAR LDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 106,837 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-24-003744 · dp208298_4-alvarez.xml · derivative · entry 2 ALVAREZ CESAR L · CIK 0001220297 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 106,837 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. F2 · derivative.exercise_date: The RSUs vested in full on March 9, 2024. F2 · derivative.expiration_date: The RSUs vested in full on March 9, 2024. Read SEC document |
| March 09, 2024 Filed Mar 12, 2024 23:52 UTC |
ALVAREZ CESAR LDirector
|
Exercise / conversionCommon Stock | 106,837 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950103-24-003744 · dp208298_4-alvarez.xml · nonDerivative · entry 1 ALVAREZ CESAR L · CIK 0001220297 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 526,227 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. Read SEC document |
| March 09, 2024 Filed Mar 12, 2024 23:47 UTC |
Turley James SDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 106,837 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-24-003741 · dp208300_4-turley.xml · derivative · entry 2 Turley James S · CIK 0001580994 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 106,837 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. F2 · derivative.exercise_date: The RSUs vested in full on March 9, 2024. F2 · derivative.expiration_date: The RSUs vested in full on March 9, 2024. Read SEC document |
| March 09, 2024 Filed Mar 12, 2024 23:47 UTC |
Turley James SDirector
|
Exercise / conversionCommon Stock | 106,837 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950103-24-003741 · dp208300_4-turley.xml · nonDerivative · entry 1 Turley James S · CIK 0001580994 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 428,735 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. Read SEC document |
| December 28, 2023 Filed Dec 29, 2023 19:30 UTC |
KIRK RANDAL JDirector · 10% owner
|
PurchaseCommon Stock | 96,686 | $1.41 | $136,327.26 |
DisclosureSEC source: 0001213900-23-100214 · marketforms-63934.xml · nonDerivative · entry 1 KIRK RANDAL J · CIK 0001091823 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · by Parkview 2020 Disclosed balance after: 1,096,686 F1 · price: On December 28, 2023, Parkview 2020 Limited Partnership ("Parkview 2020"), entered into a Stock Purchase Agreement with Jeffrey Kindler, a Director of the issuer, pursuant to which Parkview 2020 purchased from Mr. Kindler 96,686 shares of common stock of the issuer for an aggregate purchase price of $1.41, which purchase price was calculated based upon the closing price of the issuer's common stock on December 28, 2023. F2 · ownership.nature: Randal J. Kirk controls each of Parkview 2020, R.J. Kirk Declaration of Trust ("R.J. Kirk DOT"), JPK 2008 LLC ("JPK 2008"), JPK 2009 LLC ("JPK 2009"), JPK 2012 LLC ("JPK 2012"), MGK 2008 LLC ("MGK 2008"), MGK 2009 LLC ("MGK 2009"), MGK 2011 LLC ("MGK 2011"), ZSK 2008 LLC ("ZSK 2008"), ZSK 2009 LLC ("ZSK 2009"), Kellie L. Banks (2009) Long Term Trust ("Kellie L. Banks LTT"), Third Security Senior Staff 2015 LLC ("Sr. Staff 2015"), Third Security Staff 2015 LLC ("Staff 2015"), Kapital Joe, LLC ("Kapital Joe"), Lotus Capital (2000) Company, Inc. ("Lotus"), and Sunset 2020 LLC ("Sunset 2020"). Shares held by these entities may be deemed to be beneficially owned (as defined under Rule 13d-3 promulgated under the Securities Exchange Act of 1934, as amended) by Mr. Kirk. Mr. Kirk disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein. Read SEC document |
| December 28, 2023 Filed Dec 30, 2023 00:19 UTC |
KINDLER JEFFREY BDirector
|
SaleCommon Stock | 96,686 | $1.41 | $136,327.26 |
DisclosureSEC source: 0000950103-23-018125 · dp204605_4-kindler.xml · nonDerivative · entry 1 KINDLER JEFFREY B · CIK 0001174454 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 238,275 F1 · shares: On December 28, 2023, Jeffrey Kindler, a Director of the Issuer, entered into a Stock Purchase Agreement with Parkview 2020 Limited Partnership ("Parkview 2020"), an affiliate of Randal J. Kirk, also a Director of the Issuer, pursuant to which Parkview 2020 purchased from Mr. Kindler 96,686 shares of common stock of the Issuer at a price per share of $1.41, which purchase price was determined based upon the closing price of the Issuer's common stock on December 28, 2023. Read SEC document |
| September 22, 2023 Filed Sep 25, 2023 20:02 UTC |
MITCHELL DEAN JDirector
|
PurchaseCommon Stock | 25,000 | $1.41 | $35,250.00 |
DisclosureSEC source: 0000950103-23-013963 · dp200416_4-mitchell.xml · nonDerivative · entry 1 MITCHELL DEAN J · CIK 0001199297 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 356,836 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.39 to $1.44, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) this Form 4. Read SEC document |
| August 25, 2023 Filed Aug 25, 2023 23:04 UTC |
Sabzevari HelenDirector · President and CEO
|
SaleCommon Stock | 76,969 | $1.53 | $117,762.57 |
DisclosureSEC source: 0000950103-23-012774 · dp199184_4-sabzevari.xml · nonDerivative · entry 2 Sabzevari Helen · CIK 0001724195 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,560,004 F2 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs pursuant to the terms of a 10b5-1 plan adopted by the reporting person. The sale was effected through an automatic "sell to cover" transaction that did not represent a discretionary trade by the reporting person. Read SEC document |
| August 24, 2023 Filed Aug 25, 2023 23:01 UTC |
Shah Rutul RChief Operating Officer
|
SaleCommon Stock | 5,388 | $1.64 | $8,836.32 |
DisclosureSEC source: 0000950103-23-012772 · dp199183_4-shah.xml · nonDerivative · entry 2 Shah Rutul R · CIK 0001947221 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 133,474 F2 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs pursuant to the terms of a 10b5-1 plan adopted by the reporting person. The sale was effected through an automatic "sell to cover" transaction that did not represent a discretionary trade by the reporting person. Read SEC document |
| August 24, 2023 Filed Aug 25, 2023 22:59 UTC |
Thomasian Harry Jr.Chief Financial Officer
|
SaleCommon Stock | 9,045 | $1.64 | $14,833.80 |
DisclosureSEC source: 0000950103-23-012770 · dp199181_4-thomasian.xml · nonDerivative · entry 2 Thomasian Harry Jr. · CIK 0001886301 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 161,051 F2 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs pursuant to the terms of a 10b5-1 plan adopted by the reporting person. The sale was effected through an automatic "sell to cover" transaction that did not represent a discretionary trade by the reporting person. Read SEC document |
| August 24, 2023 Filed Aug 25, 2023 23:03 UTC |
Lehr Donald P.Chief Legal Officer
|
SaleCommon Stock | 10,947 | $1.64 | $17,953.08 |
DisclosureSEC source: 0000950103-23-012773 · dp199185_4-lehr.xml · nonDerivative · entry 2 Lehr Donald P. · CIK 0001583187 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 428,916 F2 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs pursuant to the terms of a 10b5-1 plan adopted by the reporting person. The sale was effected through an automatic "sell to cover" transaction that did not represent a discretionary trade by the reporting person. Read SEC document |
| August 24, 2023 Filed Aug 25, 2023 23:00 UTC |
Perez Jeffrey ThomasSVP, IP Affairs
|
SaleCommon Stock | 8,891 | $1.64 | $14,581.24 |
DisclosureSEC source: 0000950103-23-012771 · dp199182_4-perez.xml · nonDerivative · entry 2 Perez Jeffrey Thomas · CIK 0001617812 · SVP, IP Affairs 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 458,903 F2 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs pursuant to the terms of a 10b5-1 plan adopted by the reporting person. The sale was effected through an automatic "sell to cover" transaction that did not represent a discretionary trade by the reporting person. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 23:01 UTC |
Shah Rutul RChief Operating Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 15,480 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-23-012772 · dp199183_4-shah.xml · derivative · entry 3 Shah Rutul R · CIK 0001947221 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,480 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. F3 · derivative.exercise_date: Represents 1/6 of the RSUs granted on March 24, 2023 that vested on August 23, 2023. F3 · derivative.expiration_date: Represents 1/6 of the RSUs granted on March 24, 2023 that vested on August 23, 2023. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 23:01 UTC |
Shah Rutul RChief Operating Officer
|
Exercise / conversionCommon Stock | 15,480 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950103-23-012772 · dp199183_4-shah.xml · nonDerivative · entry 1 Shah Rutul R · CIK 0001947221 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 138,862 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:59 UTC |
Thomasian Harry Jr.Chief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 17,934 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-23-012770 · dp199181_4-thomasian.xml · derivative · entry 3 Thomasian Harry Jr. · CIK 0001886301 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 17,934 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. F3 · derivative.exercise_date: Represents 1/6 of the RSUs granted on March 24, 2023 that vested on August 23, 2023. F3 · derivative.expiration_date: Represents 1/6 of the RSUs granted on March 24, 2023 that vested on August 23, 2023. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:59 UTC |
Thomasian Harry Jr.Chief Financial Officer
|
Exercise / conversionCommon Stock | 17,934 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950103-23-012770 · dp199181_4-thomasian.xml · nonDerivative · entry 1 Thomasian Harry Jr. · CIK 0001886301 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 170,096 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 23:04 UTC |
Sabzevari HelenDirector · President and CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 141,587 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-23-012774 · dp199184_4-sabzevari.xml · derivative · entry 3 Sabzevari Helen · CIK 0001724195 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 141,587 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. F3 · derivative.exercise_date: Represents 1/6 of the RSUs granted on March 24, 2023 that vested on August 23, 2023. F3 · derivative.expiration_date: Represents 1/6 of the RSUs granted on March 24, 2023 that vested on August 23, 2023. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.